Skip to main content

Advertisement

SpringerLink
Log in

Evaluation of IL-8 Nasal Lavage Levels and the Effects of Nasal Involvement on Disease Severity in Patients with Stable Chronic Obstructive Pulmonary Disease

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Interleukin 8 (IL-8) is used to evaluate the severity of inflammation in the airways. The aim of this study was to evaluate patients with chronic obstructive pulmonary disease (COPD) for the presence of upper respiratory tract involvement by questioning patients regarding nasal symptoms and by measuring levels of IL-8 in nasal lavage material. A total of 47 COPD patients and 23 healthy controls were enrolled in this study. Pulmonary function tests were performed for all participants who were asked to complete a Sinonasal Outcome Test-20 (SNOT-20) questionnaire on the same day, as a measure of quality of life. Median IL-8 level in nasal lavage specimens of COPD patients with stable disease was higher than that of healthy controls. An increase in cigarette pack-years was significantly associated with an increase in nasal IL-8 levels. Similarly, IL-8 levels correlated positively with stage of COPD. A significant link between number of visits to the emergency department and stage of disease was observed. Patients with COPD had a significantly higher mean SNOT-20 severity score compared to healthy controls. Proper management of sinonasal disease may help to decrease the number of COPD attacks and consequently improve quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Mathers, C.D., and D. Loncar. 2006. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine 3: 442.

    Article  Google Scholar 

  2. American Thoracic Society. 1995. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 152(5 Pt 2): S77–S121.

    Google Scholar 

  3. Chung, K.F. 2001. Cytokines in chronic obstructive pulmonary disease. European Respiratory Journal 18(Suppl. 34): 50–59.

    Article  Google Scholar 

  4. Pease, J.E., and I. Sabroe. 2002. The role of interleukin-8 and its receptors in inflammatory lung disease: implication for therapy. American Journal of Respiratory Medicine 1: 19–25.

    Article  CAS  PubMed  Google Scholar 

  5. Nihlen, U., M. Andersson, C.G. Lofdahl, et al. 2003. Nasal neutrophil activity and mucinous secretory responsiveness in COPD. Clinical Physiology and Functional Imaging 23: 38–42.

    Article  Google Scholar 

  6. Hurst, J.R., T.M. Wilkinson, W.R. Perera, et al. 2005. Relationships among bacteria, airway, lower airway, and systemic inflammation in COPD. Chest 127: 1219–1226.

    Article  PubMed  Google Scholar 

  7. Kim, J.S., and B.K. Rubin. 2007. Nasal and sinus inflammation in chronic obstructive pulmonary disease. COPD 4: 163–166.

    Article  PubMed  Google Scholar 

  8. Hurst, J.R., T.M. Wilkinson, G.C. Donaldson, et al. 2004. Upper airway symptoms and quality of life in chronic obstructive pulmonary disease (COPD). Respiratory Medicine 98: 767–770.

    Article  PubMed  Google Scholar 

  9. Montnemery, P., C. Svensson, E. Adelroth, et al. 2001. Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema. European Respiratory Journal 17: 596–603.

    Article  CAS  PubMed  Google Scholar 

  10. Farmer, S.G., and D.W.P. Hay. 1991. The airway epithelium: physiology, pathophysiology and pharmacology. In Lung biology in health and disease, ed. C. Lenfant. USA: Marcel Dekker Inc.

    Google Scholar 

  11. Hens, G., B.M. Vanaudenaerde, D.M.A. Bullens, et al. 2008. Sinonasal pathology in nonallergic asthma and COPD: “united airway diseaseˮ beyond the scope of allergy. Allergy 63: 261–267.

    Article  CAS  PubMed  Google Scholar 

  12. Barnes, P.J., S.D. Shapiro, and R.A. Pauwels. 2003. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. European Respiratory Journal 22: 672–688.

    Article  CAS  PubMed  Google Scholar 

  13. Yamamto, C., T. Yoneda, M. Yoshikawa, et al. 1997. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest 112: 505–510.

    Article  Google Scholar 

  14. Perng, D.W., H. Huang, H.M. Chen, et al. 2004. Characteristics of airway inflammation and bronchodilator reversibility in COPD. Chest 126: 375–381.

    Article  PubMed  Google Scholar 

  15. Chang, C., and W. Yao. 2014. Time course of inflammation resolution in patients with frequent exacerbations of chronic obstructive pulmonary disease. Medical Science Monitor 20: 311–320.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Feng, E., R. Wan, S. Yang, et al. 2013. Expression levels of induced sputum IL-8 and IL-10 and drug intervention effects in patients with acute exacerbated COPD complicated with chronic cor pulmonale at high altitude. Exp Ther Med 6: 747–752.

    CAS  PubMed Central  PubMed  Google Scholar 

  17. Callebaut, I., V. Hox, S. Bobic, et al. 2013. Effect of nasal anti-inflammatory treatment in chronic obstructive pulmonary disease. American Journal of Rhinology & Allergy 27: 273–277.

    Article  Google Scholar 

  18. Barnes, P.J. 2004. Mediators of chronic obstructive pulmonary disease. Pharmacological Reviews 56: 515–548.

    Article  CAS  PubMed  Google Scholar 

  19. Hurst, J.R., W.R. Perera, T.M. Wilkinson, et al. 2006. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 173: 71–78.

    Article  CAS  PubMed  Google Scholar 

  20. Hill, A.T., E.J. Campbell, S.L. Hill, et al. 2000. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. American Journal of Medicine 109: 288–295.

    Article  CAS  PubMed  Google Scholar 

  21. O’ Donnell, R.A., C. Peebles, J.A. Ward, et al. 2004. Relationship between peripheral airway dysfunction, airway obstruction and neutrophilic inflammation in COPD. Thorax 59: 837–842.

    Article  Google Scholar 

  22. Feghali, C.A., and T.M. Wright. 1997. Cytokines in acute and chronic inflammation. Fronties in Bioscience 2: d12–d26.

    CAS  Google Scholar 

  23. Pelegrino, N.R., Tanni, S.E., Amaral, R.A. et al. 2012. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease. American Journal of Medicine Sciences. 7. [Epub ahead of print]

  24. Macnee, W. 2005. Pathogenesis of chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2: 258–266.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Roberts, N.J., S.J. Loyd-Own, F. Rapado, et al. 2003. Relationship between chronic nasal and respiratory symptoms in patients with COPD. Respiratory Medicine 97: 909–1004.

    Article  PubMed  Google Scholar 

  26. Wakabayashi, Y., Y. Usui, Y. Okunuki, et al. 2011. Increases of vitreous monocyte chemotactic protein 1 and interleukin 8 levels in patients with concurrent hypertension and diabetic retinopathy. Retina 31: 1951–1957.

    Article  CAS  PubMed  Google Scholar 

  27. Mirza, S., M. Hossain, C. Mathews, et al. 2012. Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study. Cytokine 57: 136–142.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Gokalp, D., A. Tuzcu, M. Bahceci, et al. 2009. Levels of proinflammatory cytokines and hs-CRP in patients with homozygous familial hypercholesterolaemia. Acta Cardiologica 64: 603–609.

    Article  PubMed  Google Scholar 

  29. Boekholdt, S.M., R.J. Peters, C.E. Hack, et al. 2004. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arteriosclerosis, Thrombosis, and Vascular Biology 24: 1503–1508.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

We (all authors) declare that there is no conflict of interests among the authors. There is no financial support.

Author information

Authors and Affiliations

  1. Department of Pulmonary, Ataturk Chest Disease and Chest Surgery Training and Research Hospital, Ankara, Turkey

    Hacer Celik, Serdar Akpinar, Berna Dursun, Huyla Celenk Erguden, Sibel Gunay & Tugrul Sipit

  2. Department of Otolaryngology and Audiology, Ankara Kecioren Research and Training Hospital, Ankara, Turkey

    Hayriye Karabulut

  3. Department of Biology, Gazi University, Ankara, Turkey

    Pinar Oktar

Authors
  1. Hacer Celik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Serdar Akpinar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hayriye Karabulut
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pinar Oktar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Berna Dursun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Huyla Celenk Erguden
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sibel Gunay
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tugrul Sipit
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hacer Celik.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Celik, H., Akpinar, S., Karabulut, H. et al. Evaluation of IL-8 Nasal Lavage Levels and the Effects of Nasal Involvement on Disease Severity in Patients with Stable Chronic Obstructive Pulmonary Disease. Inflammation 38, 616–622 (2015). https://doi.org/10.1007/s10753-014-9968-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-014-9968-0

KEY WORDS

Search

Navigation